Psychoeducation for bipolar II disorder: An exploratory, 5-year outcome subanalysis

被引:65
作者
Colom, F.
Vieta, E. [1 ]
Sanchez-Moreno, J.
Goikolea, J. M.
Popova, E.
Bonnin, C. M.
Scott, J. [2 ,3 ]
机构
[1] Univ Barcelona, CIBERSAM, IDIBAPS, Hosp Clin,Inst Neurosci,Bipolar Disorders Program, Catalonia, Spain
[2] Newcastle Univ, Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[3] Inst Psychiat, London, England
关键词
Bipolar II disorder; Psychoeducation; Relapse prevention; Psychotherapy; MAINTENANCE TREATMENT; DEPRESSION; IMPAIRMENT; DISABILITY; EFFICACY; LITHIUM; MANIA;
D O I
10.1016/j.jad.2008.03.023
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Background: Bipolar II represents a significant subgroup of bipolar patients. However, there is limited evidence regarding the efficacy of pharmacological and/or psychosocial therapies. Method: Post-hoc analyses were undertaken using data on 20 (Out Of 120) patients who fulfilled DSM-IV criteria for BP II who had participated in a single-blind randomized controlled treatment trial (RCT) exploring the acute and long-term efficacy of group psychoeducation plus standard pharmacological treatment as compared with unstructured support groups Plus standard pharmacological treatment. Eight BP II subjects had been randomized to a psychoeducation group and 12 to an unstructured support group. Results: Psychoeducated, as compared to control group bipolar II patients, had significantly better 5-year outcomes, with lower mean number of BP episodes (p <.02), hypomanic episodes (p <.03) and depressive episodes (p <.03), fewer days spent in mood episodes (p=.004) and higher mean levels of functioning (p <.05). Conclusions: Although these findings should be treated with caution, it appears that psychoeducation plus medication call benefit bipolar II subjects. Dedicated treatment trials will need to clarify whether these therapies require modifications in duration and/or content to meet the needs of bipolar II patients. (c) 2008 Elsevier B.V All rights reserved.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 27 条
[1]
Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes [J].
Albert, Umberto ;
Rosso, Gianluca ;
Maina, Giuseppe ;
Bogetto, Filippo .
JOURNAL OF AFFECTIVE DISORDERS, 2008, 105 (1-3) :297-303
[2]
Amsterdam JD, 2000, J AFFECT DISORDERS, V59, P225, DOI 10.1016/S0165-0327(99)00149-4
[3]
Efficacy and safety of fluoxetine in treating bipolar II major depressive episode [J].
Amsterdam, JD ;
Garcia-España, F ;
Fawcett, J ;
Quitkin, FM ;
Reimherr, FW ;
Rosenbaum, JF ;
Schweizer, E ;
Beasley, C .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (06) :435-440
[4]
Bipolar II disorder: a review [J].
Berk, M ;
Dodd, S .
BIPOLAR DISORDERS, 2005, 7 (01) :11-21
[5]
Depression subtypes in bipolar I and II disorders [J].
Brugue, E. ;
Colom, F. ;
Sanchez-Moreno, J. ;
Cruz, N. ;
Vieta, E. .
PSYCHOPATHOLOGY, 2008, 41 (02) :111-114
[6]
A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission [J].
Colom, F ;
Vieta, E ;
Martínez-Arán, A ;
Reinares, M ;
Goikolea, JM ;
Benabarre, A ;
Torrent, C ;
Comes, M ;
Corbella, B ;
Parramon, G ;
Corominas, J .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (04) :402-407
[7]
Colom F., 2006, PSYCHOEDUCATION MANU, VFirst
[8]
COLOM F, BR J PSYCHI IN PRESS
[9]
El-Mallakh Rif, 2006, Ann Clin Psychiatry, V18, P259, DOI 10.1080/10401230600948480
[10]
Greil W, 1999, INT CLIN PSYCHOPHARM, V14, P283